Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

The design of DNA vaccination delivery systems for the targeting of professional antigen presenting cells could be an interesting approach to elicit cytotoxic T-cell responses to fight viral infections and in cancer therapy. Stability studies with linear high and low molecular DNA and supercoiled plasmid DNA were performed in order to check their ability to withstand stress conditions applied during formulation processes. DNA was tested for integrity by the PicoGreen assay and transfectivity was assessed in cell culture transfection experiments. Double-stranded DNA is extremely stable under physiological conditions in vitro but is rapidly degraded under acidic conditions and high shear forces. Thereby, different stress factors resulted in distinct degradation patterns such as fragmentation and strand separation possibly followed by further decomposition of single-stranded DNA. DNA containing PLGA microparticles as a potential delivery system was prepared by spray-drying. Encapsulation efficiency, DNA stability and burst release varied significantly depending on the different parameters explored in this study. The microencapsulation process was altered to achieve maximal stability of encapsulated DNA by reducing exposure to shear forces and by the addition of NaHCO(3) which acts as a buffering agent and furthermore stabilizes dsDNA against mechanical degradation. Stability of DNA is maintained during the burst release phase, but massive degradation occurred during the second release phase possibly due to acidic catalyzed decomposition. In summary, we feel that microencapsulation of DNA vaccines by spray-drying offers manifold possibilities to design suitable delivery systems in terms of optimizing phagocytosis by APCs and maintaining stability of DNA in phagosomes.

[1]  M. Bally,et al.  Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. , 1996, Journal of pharmaceutical sciences.

[2]  R. K. Evans,et al.  Analysis of plasmid DNA from a pharmaceutical perspective. , 1998, Journal of pharmaceutical sciences.

[3]  T. Lindahl,et al.  Rate of depurination of native deoxyribonucleic acid. , 1972, Biochemistry.

[4]  B. Gander,et al.  Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.

[5]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[6]  M. Hedley,et al.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses , 1998, Nature Medicine.

[7]  O. Zelphati,et al.  Analytical methods for the characterization of cationic lipid-nucleic acid complexes. , 1998, Human gene therapy.

[8]  Hans P. Merkle,et al.  Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response , 1996 .

[9]  R. Mumper,et al.  Plasmid delivery to muscle: Recent advances in polymer delivery systems. , 1998, Advanced drug delivery reviews.

[10]  A. Rundell,et al.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. , 1993, Human gene therapy.

[11]  J. Shiver,et al.  Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza , 1996 .

[12]  T. Tsong,et al.  Study of mechanisms of electric field-induced DNA transfection. IV. Effects of DNA topology on cell uptake and transfection efficiency. , 1992, Biophysical journal.

[13]  T. Lindahl,et al.  Rate of chain breakage at apurinic sites in double-stranded deoxyribonucleic acid. , 1972, Biochemistry.

[14]  G. Chalepakis,et al.  Hormonal induction of transfected genes depends on DNA topology , 1990, Molecular and cellular biology.

[15]  D. Weiner,et al.  Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. , 1998, Journal of immunology.

[16]  T. Burke,et al.  Evidence for an acidic microclimate in PLGA microspheres , 1998 .

[17]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[18]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[19]  D. Bergstrom,et al.  dsDNA stability dependence on pH and salt concentration. , 1998, BioTechniques.

[20]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. R. Garrett,et al.  Solvolysis of adenine nucleosides. I. Effects of sugars and adenine substituents on acid solvolyses. , 1972, Journal of the American Chemical Society.

[22]  J. Yewdell,et al.  MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.

[23]  B. Gander,et al.  A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation , 1996 .

[24]  G. Repetto,et al.  Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. , 1992, Journal of cell science.

[25]  C. Walker,et al.  Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.